Australian Dollar Rises Against Majors

The Australian dollar strengthened against other major currencies in the Asian session on Wednesday. The Australian dollar rose to 2-day highs of 1.6650 against the euro, 0.8856 against the Canadian dollar and 1.0701 against the NZ dollar, from yesterday\'s closing quotes of 1.6687, 0.8837 and 1.0680, respectively. Against the U.S. dollar, the aussie edged up...

Read More

NZ Dollar Advances Against Most Majors

The New Zealand dollar strengthened against most major currencies in the Asian session on Wednesday. The NZ dollar rose to 0.6099 against the U.S. dollar and 91.40 against the yen, from an early 3-week low of 0.6069 and a 6-day low of 91.04 against the yen, respectively. Against the euro, the kiwi edged up to...

Read More

Yen Rises Against Majors

The Japanese yen strengthened against other major currencies in the European session on Wednesday. The yen rose to a 5-day high of 162.21 against the euro and a 2-day high of 189.86 against the pound, from early lows of 162.89 and 190.63, respectively. Against the U.S. dollar and the Swiss franc, the yen advanced to...

Read More

Powell Says Rate Cuts Likely This Year But Still Needs \'Greater Confidence\' Inflation Is Slowing

Federal Reserve Chair Jerome Powell will tell members of Congress on Wednesday that it will likely be appropriate for the central bank to begin lowering interest rates at \"some point this year\" but reiterated officials need \"greater confidence\" inflation is moving sustainably toward 2 percent. In prepared remarks before the House Financial Services Committee, Powell...

Read More

J&J Seeks EMA Approval For DARZALEX Quadruplet Therapy For Multiple Myeloma

Janssen-Cilag International NV, a Johnson & Johnson company (JNJ), announced Wednesday the submission of a Type II variation application to the European Medicines Agency (EMA). The submission is seeking approval for an indication extension of DARZALEX (daratumumab) subcutaneous (SC) formulation in combination with bortezomib, lenalidomide, and dexamethasone (D-VRd) for the treatment of adult patients with...

Read More